Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
about
Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.A proposal to use iterative, small clinical trials to optimize therapeutic HIV vaccine immunogens to launch therapeutic HIV vaccine development.Kill: boosting HIV-specific immune responses.Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function
P2860
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@en
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@nl
type
label
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@en
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@nl
prefLabel
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@en
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@nl
P2093
P2860
P1476
Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
@en
P2093
Chloe K Slichter
David P Friedrich
Julie L Czartoski
Nicole Frahm
Paula N Walsh
Rebecca J Smith
P2860
P356
10.1016/J.JIM.2013.12.006
P577
2013-12-25T00:00:00Z